½ÃÀ庸°í¼­
»óǰÄÚµå
1388127

°æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå : Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ - Á¦Ç°º°, ¿ëµµº°, ÀûÀÀÁõº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2023-2032³â)

Kyphoplasty Market Share, Size, Trends, Industry Analysis Report, By Product, By Application, By Indication, By End-use, By Region, And Segment Forecasts, 2023 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 118 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 10¾ï 4,838¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

¾Ð¹Ú °ñÀýÀº Àü ¼¼°è ¸¹Àº »ç¶÷µé¿¡°Ô Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. °ñ´Ù°øÁõ ȯÀÚ¿¡¼­ ¹ß»ýÇÏ´Â °ñÀý Áß Ã´Ã߾йڰñÀý(VCF)ÀÌ °¡Àå ÈçÇÑ °ñÀý·Î ¿¬°£ ¾à 750,000¸íÀÌ ¹ß»ýÇϸç, VCFÀÇ ¹ß»ý·üÀº ¿¬·ÉÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¡Â÷ Áõ°¡ÇÏ´Â °æÇâÀ» º¸À̸ç, 80¼¼ ÀÌ»ó ¿©¼ºÀÇ 40%°¡ ÀÌ ÁúȯÀ» ¾Î°í ÀÖ´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

COVID-19´Â Àü ¼¼°è ôÃ߿ܰú ÀÇ»çµéÀÇ ¼ö¼ú°ú ÀÓ»ó¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çôÃßÇÐȸ(APSS)°¡ ½Ç½ÃÇÑ ¼³¹®Á¶»ç¿¡ µû¸£¸é, Àü¿°º´Àº ôÃ߿ܰú ÀÇ»çµéÀÇ ÀÓ»ó¿¡¼­ Å« º¯È­¸¦ °¡Á®¿Ô´Ù°í ÇÕ´Ï´Ù. ÀÌ ¼³¹®Á¶»ç´Â 19°³±¹À» ´ëÇ¥ÇÏ´Â ÃÑ 222¸íÀÇ Âü°¡ÀڷκÎÅÍ ÀÀ´äÀ» ¹Þ¾Ò½À´Ï´Ù. ±× °á°ú, ¸ðµç ±¹°¡¿¡¼­ Áø·á·®ÀÌ Æò±Õ 48.1% °¨¼ÒÇÑ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ±× °á°ú, ¸»·¹À̽þÆ, ÀϺ», Àεµ, Çʸ®ÇÉ, Çѱ¹ µîÀÇ ±¹°¡¿¡¼­´Â ÀÌ ±â°£ µ¿¾È ¼ö¼ú °Ç¼ö°¡ ´«¿¡ ¶ç°Ô °¨¼ÒÇß½À´Ï´Ù.

Àΰø °ñµÎ ¼ºÇü¼úÀº º¸Á¸Àû Ä¡·á¹ý¿¡ ºñÇØ ´õ ºü¸¥ ÅëÁõ ¿ÏÈ­ ¹× ±â´ÉÀû °á°ú °³¼±À» °¡Á®¿É´Ï´Ù. ´Ù¹ß¼º °ñ¼öÁ¾(µî»À¸¦ ¾àÈ­½ÃŰ´Â ¾ÏÀÇ ÀÏÁ¾)ÀÇ °æ¿ì °ñÀý°ú Èĸ¸Áõ(ôÃß°¡ ºñÁ¤»óÀûÀ¸·Î ÈÖ¾îÁö´Â Çö»ó)ÀÌ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇÑÆí, Àå½Ã°£ ¾É¾Æ Àְųª À߸øµÈ ÀÚ¼¼µµ Èĸ¸ÁõÀÇ ¿øÀÎÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. Àå½Ã°£ ¾É¾ÆÀÖÀ» ¶§ ôÃß¿¡ °¡ÇØÁö´Â ¾Ð·ÂÀº ôÃßÀÇ ÅðÇà°ú Èĸ¸ÁõÀÇ Çü¼ºÀ¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù.

ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÀÇ·áºñ »óȯ Á¤Ã¥ °³¼±, ½ÅÁ¦Ç° ±â¼ú ¹ßÀü, °ñ´Ù°øÁõ ¹ßº´·ü Áõ°¡ µîÀ¸·Î ÀÎÇØ ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â 9¿ù ½ºÆ®¶óÀÌÄ¿(Stryker)ÀÇ °ñÀý °¨¼Ò ½Ã½ºÅÛ SpineJackÀÌ ¹Ì±¹ ¸ÞµðÄɾî&¸ÞµðÄÉÀÌµå ¼­ºñ½º ¼¾ÅÍ(CMS)ÀÇ ½Å±â¼ú °¡»ê ÁöºÒ, 2021³â ÀÔ¿ø ȯÀÚ ÀüÇâÀû ÁöºÒ ½Ã½ºÅÛÀ» ȹµæÇÏ¿© ÀÌ ºÐ¾ßÀÇ Çõ½ÅÀû ¹ßÀü¿¡ ´ëÇÑ ÀÎÁ¤°ú Áö¿øÀ» ¹Þ¾Ò½À´Ï´Ù. ¸¦ °­Á¶Çϰí ÀÖ½À´Ï´Ù.

°æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

°ñÀý ¹× ¿¬°ñ ¾Ð¹Ú ¼Õ»óÀÇ Áõ°¡·Î ÀÎÇØ »À Á¢±Ù ºÎ¹®ÀÌ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

dz¼± Ä«Å×ÅÍ´Â ±â¼úÀÇ ¹ßÀü°ú ÃÖ¼Ò Ä§½À ¼ö¼úÀÇ Áõ°¡·Î ¾ÈÁ¤ÀûÀÎ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

ºÏ¹Ì Áö¿ªÀÌ ÀÇ·á ÀÎÇÁ¶ó°¡ Àß °®Ãß¾îÁ® ÀÖ°í, »óȯ ½Ã³ª¸®¿À·Î ÀÎÇØ ºÏ¹Ì Áö¿ªÀÌ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå¿¡ °üÇÑ ÀλçÀÌÆ®

  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú - ¾÷°è ÇöȲ
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
    • ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
  • PESTLE ºÐ¼®
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ¾÷°è µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19 °¨¿°ÁõÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, Á¦Ç°º°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • dz¼± Ä«Å×ÅÍ
  • »À ¾×¼¼½º µð¹ÙÀ̽º
  • ½Ã¸àÆ® ¾ÖÇø®ÄÉÀÌ¼Ç Á¦Ç°
  • »À ½Ã¸àÆ®
  • ½Ã¸àÆ® È¥ÇÕ ½Ã½ºÅÛ
  • ±â±â

Á¦6Àå ¼¼°èÀÇ °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • Ãß°ñ Á¤·Ä ȸº¹
  • ôÃß °ñÀý
  • ôÃß Èĸ¸Áõ

Á¦7Àå ¼¼°èÀÇ °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, ÀûÀÀÁõº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • °ñ´Ù°øÁõ
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, ÃÖÁ¾ ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • º´¿ø¡¤Å¬¸®´Ð
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ

Á¦9Àå ¼¼°èÀÇ °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå Æò°¡, Áö¿ªº°, 2019-2032³â
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - ºÏ¹Ì
    • ºÏ¹Ì : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, Á¦Ç°º°, 2019-2032³â
    • ºÏ¹Ì : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019-2032³â
    • ºÏ¹Ì : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, ¿ëµµº°, 2019-2032³â
    • ºÏ¹Ì : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, ÀûÀÀÁõº°, 2019-2032³â
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - ¹Ì±¹
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - ij³ª´Ù
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - À¯·´
    • À¯·´ : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, Á¦Ç°º°, 2019-2032³â
    • À¯·´ : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019-2032³â
    • À¯·´ : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, ¿ëµµº°, 2019-2032³â
    • À¯·´ : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, ÀûÀÀÁõº°, 2019-2032³â
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - ¿µ±¹
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - ÇÁ¶û½º
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - µ¶ÀÏ
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - ÀÌÅ»¸®¾Æ
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - ½ºÆäÀÎ
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - ³×´ú¶õµå
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - ·¯½Ã¾Æ
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, Á¦Ç°º°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, ¿ëµµº°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ôÁÖ °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, ÀûÀÀÁõº°, 2019-2032³â
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - Áß±¹
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - Àεµ
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå-ÀϺ»
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - ¸»·¹À̽þÆ
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - Àεµ³×½Ã¾Æ
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - Çѱ¹
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, Á¦Ç°º°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, ¿ëµµº°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, ÀûÀÀÁõº°, 2019-2032³â
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - À̽º¶ó¿¤
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - ¾Æ¶ø¿¡¹Ì¸®Æ®
  • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, Á¦Ç°º°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, ÃÖÁ¾ ¿ëµµº°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, ¿ëµµº°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå, ÀûÀÀÁõº°, 2019-2032³â
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - ¸ß½ÃÄÚ
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - ºê¶óÁú
    • °æÇÇÀûdz¼±Ã´Ãß¼ºÇü¼ú ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª

Á¦10Àå °æÀï »óȲ

  • È®´ë¿Í Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦11Àå ±â¾÷ °³¿ä

  • DePuy Synthes
  • Hensler Surgical Products
  • iMEDICOM
  • IZI Medical Products
  • Jiangsu ChangMei Medtech
  • Joimax GmbH
  • Joline GmbH
  • Medtronic
  • MicroPort Scientific
  • Seawon Meditech
  • Smith & Nephew
  • Stryker
  • Taeyeon Medical
ksm 23.12.19

The global kyphoplasty market size is expected to reach USD 1048.38 million by 2032, according to a new study by Polaris market research. The report "Kyphoplasty Market Share, Size, Trends, Industry Analysis Report, By Product (Balloon Catheters, Bone Access Devices, Cement Application Products, Bone Cement, Cement Mixing Systems, Instruments), By Application, By Indication, By End-use, By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Compression fractures have a significant impact on many individuals worldwide. Among fractures occurring in osteoporosis patients, vertebral compression fractures (VCFs) are the most prevalent, affecting approximately 750,000 individuals annually. Incidence of VCFs tends to increase gradually with age, with an estimated 40% of women aged 80 and older being affected by this condition.

COVID-19 pandemic has had a profound impact on the surgical and clinical practices of spine surgeons worldwide. According to a survey conducted by the Asia Pacific Spine Society (APSS), the pandemic has brought about significant changes in the clinical practices of spine surgeons. The survey gathered responses from a total of 222 participants representing 19 different countries. The findings revealed that there was an average reduction of 48.1% in clinic volume across all nations. Consequently, countries such as Malaysia, Japan, India, the Philippines, and South Korea experienced a notable decline in the number of surgeries performed during this period.

Kyphoplasty provides faster pain relief and improved functional outcomes compared to conservative treatment methods. In the case of multiple myeloma, a type of cancer that weakens the back bones, fractures, & kyphosis (abnormal curvature of the spine) can occur. On the other hand, prolonged sitting and poor posture can also contribute to the development of kyphosis. The pressure exerted on the vertebrae during extended periods of sitting can lead to their degeneration and subsequent formation of kyphosis.

Market is anticipated to witness growth during the forecast period, due to rising demand for minimally invasive surgical procedures, improvements in health reimbursement policies, technological advancements in new products, and an increasing incidence of osteoporosis. For example, in September 2020, Stryker's SpineJack implantable fracture reduction system obtained the U.S. Centers for Medicare & Medicaid Services (CMS) new technology add-on payment, in 2021, in-patient prospective payment system, highlighting the recognition and support for innovative advancements in the field.

Kyphoplasty Market Report Highlights

Bone access segment held the largest share, due to rising cases of bone fractures, and compression damages to cartilages

Balloon catheters expected to grow at steady rate, owing to advancements in technology, and rise in minimally invasive surgeries

North America region held the largest share, due to presence of well-developed medical infrastructure, and reimbursement scenario

The global key market players include: Stryker, Hensler Surgical Products, Medtronic, Smith & Nephew, MicroPort Scientific, and DePuy Synthes

Polaris market research has segmented the kyphoplasty market report based on product, application, indication, end use, and region:

Kyphoplasty, Product Outlook (Revenue - USD Million, 2023 - 2032)

  • Balloon Catheters
  • Bone Access Devices
  • Cement Application Products
  • Bone Cement
  • Cement Mixing Systems
  • Instruments

Kyphoplasty, Application Outlook (Revenue - USD Million, 2023 - 2032)

  • Vertebral Alignment Restoration
  • Spinal Fractures
  • Kyphosis

Kyphoplasty, Indication Outlook (Revenue - USD Million, 2023 - 2032)

  • Osteoporosis
  • Others

Kyphoplasty, End Use Outlook (Revenue - USD Million, 2023 - 2032)

  • Hospitals & Clinics
  • Ambulatory Surgical Centers

Kyphoplasty, Regional Outlook (Revenue - USD Million, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Kyphoplasty Market Insights

  • 4.1. Kyphoplasty - Industry Snapshot
  • 4.2. Kyphoplasty Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancement in technology
      • 4.2.1.2. Increasing Aging Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited Reimbursement
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Kyphoplasty Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Kyphoplasty Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Kyphoplasty Market, by Product, 2019-2032 (USD Million)
  • 5.3. Balloon Catheters
    • 5.3.1. Global Kyphoplasty Market, by Balloon Catheters, by Region, 2019-2032 (USD Million)
  • 5.4. Bone Access Devices
    • 5.4.1. Global Kyphoplasty Market, by Bone Access Devices, by Region, 2019-2032 (USD Million)
  • 5.5. Cement Application Products
    • 5.5.1. Global Kyphoplasty Market, by Cement Application Products, by Region, 2019-2032 (USD Million)
  • 5.6. Bone Cement
    • 5.6.1. Global Kyphoplasty Market, by Bone Cement, by Region, 2019-2032 (USD Million)
  • 5.7. Cement Mixing Systems
    • 5.7.1. Global Kyphoplasty Market, by Cement Mixing Systems, by Region, 2019-2032 (USD Million)
  • 5.8. Instruments
    • 5.8.1. Global Kyphoplasty Market, by Instruments, by Region, 2019-2032 (USD Million)

6. Global Kyphoplasty Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Kyphoplasty Market, by Application, 2019-2032 (USD Million)
  • 6.3. Vertebral Alignment Restoration
    • 6.3.1. Global Kyphoplasty Market, by Vertebral Alignment Restoration, by Region, 2019-2032 (USD Million)
  • 6.4. Spinal Fractures
    • 6.4.1. Global Kyphoplasty Market, by Spinal Fractures, by Region, 2019-2032 (USD Million)
  • 6.5. Kyphosis
    • 6.5.1. Global Kyphoplasty Market, by Kyphosis, by Region, 2019-2032 (USD Million)

7. Global Kyphoplasty Market, by Indication

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
  • 7.3. Osteoporosis
    • 7.3.1. Global Kyphoplasty Market, by Osteoporosis, by Region, 2019-2032 (USD Million)
  • 7.4. Others
    • 7.4.1. Global Kyphoplasty Market, by Others, by Region, 2019-2032 (USD Million)

8. Global Kyphoplasty Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
  • 8.3. Hospitals & Clinics
    • 8.3.1. Global Kyphoplasty Market, by Hospitals & Clinics, by Region, 2019-2032 (USD Million)
  • 8.4. Ambulatory Surgical Centers
    • 8.4.1. Global Kyphoplasty Market, by Ambulatory Surgical Centers, by Region, 2019-2032 (USD Million)

9. Global Kyphoplasty Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Kyphoplasty Market Assessment, By Geography, 2019-2032 (USD Million)
  • 9.3. Kyphoplasty Market - North America
    • 9.3.1. North America: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
    • 9.3.2. North America: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
    • 9.3.3. North America: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
    • 9.3.4. North America: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.3.5. Kyphoplasty Market - U.S.
      • 9.3.5.1. U.S.: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.3.5.2. U.S.: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.3.5.3. U.S.: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.3.5.4. U.S.: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.3.6. Kyphoplasty Market - Canada
      • 9.3.6.1. Canada: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.3.6.2. Canada: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.3.6.3. Canada: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.3.6.4. Canada: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
  • 9.4. Kyphoplasty Market - Europe
    • 9.4.1. Europe: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
    • 9.4.2. Europe: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
    • 9.4.3. Europe: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
    • 9.4.4. Europe: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.4.5. Kyphoplasty Market - UK
      • 9.4.5.1. UK: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.4.5.2. UK: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.4.5.3. UK: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.4.5.4. UK: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.4.6. Kyphoplasty Market - France
      • 9.4.6.1. France: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.4.6.2. France: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.4.6.3. France: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.4.6.4. France: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.4.7. Kyphoplasty Market - Germany
      • 9.4.7.1. Germany: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.4.7.2. Germany: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.4.7.3. Germany: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.4.7.4. Germany: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.4.8. Kyphoplasty Market - Italy
      • 9.4.8.1. Italy: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.4.8.2. Italy: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.4.8.3. Italy: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.4.8.4. Italy: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.4.9. Kyphoplasty Market - Spain
      • 9.4.9.1. Spain: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.4.9.2. Spain: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.4.9.3. Spain: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.4.9.4. Spain: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.4.10. Kyphoplasty Market - Netherlands
      • 9.4.10.1. Netherlands: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.4.10.2. Netherlands: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.4.10.3. Netherlands: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.4.10.4. Netherlands: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.4.11. Kyphoplasty Market - Russia
      • 9.4.11.1. Russia: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.4.11.2. Russia.: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.4.11.3. Russia: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.4.11.4. Russia: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
  • 9.5. Kyphoplasty Market - Asia Pacific
    • 9.5.1. Asia Pacific: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
    • 9.5.2. Asia Pacific: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
    • 9.5.3. Asia Pacific: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
    • 9.5.4. Asia Pacific: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.5.5. Kyphoplasty Market - China
      • 9.5.5.1. China: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.5.5.2. China.: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.5.5.3. China: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.5.5.4. China: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.5.6. Kyphoplasty Market - India
      • 9.5.6.1. India: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.5.6.2. India.: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.5.6.3. India: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.5.6.4. India: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.5.7. Kyphoplasty Market - Japan
      • 9.5.7.1. Japan: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.5.7.2. Japan.: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.5.7.3. Japan: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.5.7.4. Japan: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.5.8. Kyphoplasty Market - Malaysia
      • 9.5.8.1. Malaysia: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.5.8.2. Malaysia.: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.5.8.3. Malaysia: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.5.8.4. Malaysia: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.5.9. Kyphoplasty Market - Indonesia
      • 9.5.9.1. Indonesia: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.5.9.2. Indonesia.: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.5.9.3. Indonesia: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.5.9.4. Indonesia: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.5.10. Kyphoplasty Market - South Korea
      • 9.5.10.1. South Korea: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.5.10.2. South Korea.: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.5.10.3. South Korea: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.5.10.4. South Korea: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
  • 9.6. Kyphoplasty Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
    • 9.6.2. Middle East & Africa: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
    • 9.6.3. Middle East & Africa: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
    • 9.6.4. Middle East & Africa: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.6.5. Kyphoplasty Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.6.5.2. Saudi Arabia: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.6.5.3. Saudi Arabia: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.6.5.4. Saudi Arabia: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.6.6. Kyphoplasty Market - South Africa
      • 9.6.6.1. South Africa: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.6.6.2. South Africa: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.6.6.3. South Africa: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.6.6.4. South Africa: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.6.7. Kyphoplasty Market - Israel
      • 9.6.7.1. Israel: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.6.7.2. Israel: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.6.7.3. Israel: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.6.7.4. Israel: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.6.8. Kyphoplasty Market - UAE
      • 9.6.8.1. UAE: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.6.8.2. UAE: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.6.8.3. UAE: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.6.8.4. UAE: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
  • 9.7. Kyphoplasty Market - Latin America
    • 9.7.1. Latin America: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
    • 9.7.2. Latin America: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
    • 9.7.3. Latin America: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
    • 9.7.4. Latin America: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.7.5. Kyphoplasty Market - Mexico
      • 9.7.5.1. Mexico: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.7.5.2. Mexico: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.7.5.3. Mexico: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.7.5.4. Mexico: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.7.6. Kyphoplasty Market - Brazil
      • 9.7.6.1. Brazil: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.7.6.2. Brazil: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.7.6.3. Brazil: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.7.6.4. Brazil: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)
    • 9.7.7. Kyphoplasty Market - Argentina
      • 9.7.7.1. Argentina: Kyphoplasty Market, by Product, 2019-2032 (USD Million)
      • 9.7.7.2. Argentina: Kyphoplasty Market, by End Use, 2019-2032 (USD Million)
      • 9.7.7.3. Argentina: Kyphoplasty Market, by Application, 2019-2032 (USD Million)
      • 9.7.7.4. Argentina: Kyphoplasty Market, by Indication, 2019-2032 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. DePuy Synthes
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Hensler Surgical Products
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. iMEDICOM
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. IZI Medical Products
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Jiangsu ChangMei Medtech
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Joimax GmbH
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Joline GmbH
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Medtronic
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. MicroPort Scientific
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Seawon Meditech
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Smith & Nephew
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Stryker
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Taeyeon Medical
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦